US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 42.250
  • -0.180-0.42%
Close Apr 25 16:00 ET
  • 43.990
  • +1.740+4.12%
Post 17:26 ET
2.66BMarket Cap-57876P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-16.81%54.12M
-9.99%15.03M
-12.14%12.98M
-25.30%13.19M
-18.89%12.93M
65.06M
16.7M
135.68%14.77M
-45.99%17.65M
15.94M
Selling and administrative expenses
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
2.65%5.75M
122.10%6.25M
--5.49M
-General and administrative expense
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
2.65%5.75M
122.10%6.25M
--5.49M
Research and development costs
-24.37%31.8M
-28.77%8.1M
-15.95%7.59M
-23.65%8.7M
-29.08%7.42M
--42.05M
--11.37M
1,247.88%9.02M
-61.83%11.4M
--10.45M
Operating profit
16.81%-54.12M
9.99%-15.03M
12.14%-12.98M
25.30%-13.19M
18.89%-12.93M
-65.06M
-16.7M
-135.68%-14.77M
45.99%-17.65M
-15.94M
Net non-operating interest income expense
Other net income (expense)
1,613.34%10.14M
2,900.28%7.19M
3,587.69%1.39M
243.76%842.65K
941.05%723.59K
591.73K
239.51K
280.39%37.59K
6,584.92%245.13K
69.51K
Other non- operating income (expenses)
1,613.34%10.14M
2,900.28%7.19M
3,587.69%1.39M
243.76%842.65K
941.05%723.59K
--591.73K
--239.51K
280.39%37.59K
6,584.92%245.13K
--69.51K
Income before tax
31.77%-43.98M
52.34%-7.84M
21.33%-11.59M
29.09%-12.34M
23.09%-12.21M
-64.47M
-16.46M
-134.30%-14.73M
46.74%-17.41M
-15.87M
Income tax
159.55%94.39K
302.36%44.31K
230.93%28.92K
9.34%10.15K
50.16%11.01K
36.37K
11.01K
8.74K
9.28K
7.33K
Net income
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-64.51M
-16.47M
-134.44%-14.74M
46.72%-17.42M
-15.88M
Net income continuous Operations
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
---64.51M
---16.47M
-134.44%-14.74M
46.72%-17.42M
---15.88M
Minority interest income
44.46%-8.07M
-170.37%-450.31K
52.64%-2.19M
58.19%-2.21M
-3.21M
-14.53M
639.89K
-4.63M
-5.3M
0
Net income attributable to the parent company
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
-60.79%-10.11M
62.92%-12.12M
-15.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
-60.79%-10.11M
62.92%-12.12M
-15.88M
Basic earnings per share
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
-58.55%-0.27
61.59%-0.34
-0.4301
Diluted earnings per share
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
-58.55%-0.27
61.59%-0.34
-0.4301
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -16.81%54.12M-9.99%15.03M-12.14%12.98M-25.30%13.19M-18.89%12.93M65.06M16.7M135.68%14.77M-45.99%17.65M15.94M
Selling and administrative expenses -3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M2.65%5.75M122.10%6.25M--5.49M
-General and administrative expense -3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M2.65%5.75M122.10%6.25M--5.49M
Research and development costs -24.37%31.8M-28.77%8.1M-15.95%7.59M-23.65%8.7M-29.08%7.42M--42.05M--11.37M1,247.88%9.02M-61.83%11.4M--10.45M
Operating profit 16.81%-54.12M9.99%-15.03M12.14%-12.98M25.30%-13.19M18.89%-12.93M-65.06M-16.7M-135.68%-14.77M45.99%-17.65M-15.94M
Net non-operating interest income expense
Other net income (expense) 1,613.34%10.14M2,900.28%7.19M3,587.69%1.39M243.76%842.65K941.05%723.59K591.73K239.51K280.39%37.59K6,584.92%245.13K69.51K
Other non- operating income (expenses) 1,613.34%10.14M2,900.28%7.19M3,587.69%1.39M243.76%842.65K941.05%723.59K--591.73K--239.51K280.39%37.59K6,584.92%245.13K--69.51K
Income before tax 31.77%-43.98M52.34%-7.84M21.33%-11.59M29.09%-12.34M23.09%-12.21M-64.47M-16.46M-134.30%-14.73M46.74%-17.41M-15.87M
Income tax 159.55%94.39K302.36%44.31K230.93%28.92K9.34%10.15K50.16%11.01K36.37K11.01K8.74K9.28K7.33K
Net income 31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M-64.51M-16.47M-134.44%-14.74M46.72%-17.42M-15.88M
Net income continuous Operations 31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M---64.51M---16.47M-134.44%-14.74M46.72%-17.42M---15.88M
Minority interest income 44.46%-8.07M-170.37%-450.31K52.64%-2.19M58.19%-2.21M-3.21M-14.53M639.89K-4.63M-5.3M0
Net income attributable to the parent company 27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M-60.79%-10.11M62.92%-12.12M-15.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M-60.79%-10.11M62.92%-12.12M-15.88M
Basic earnings per share 57.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31-58.55%-0.2761.59%-0.34-0.4301
Diluted earnings per share 57.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31-58.55%-0.2761.59%-0.34-0.4301
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg